BioPharm International: Feb 20, 2015
The fast growth of the global biopharmaceutical market has prompted global pharmaceutical and biotechnology companies to increase their R&D investment in biologics.
BioPharm International: Feb 19, 2015
The draft guidance contains policies for drugs that are processed with additional manufacturing steps such as remixing, dilution, and repackaging.
BioPharm International: Feb 17, 2015
By BioPharm International Editors
The agency releases five draft guidance documents related to drug compounding and repackaging.
BioPharm International: Feb 01, 2015
Market forces may limit the success of CMOs.
Jan 21, 2015
By BioPharm International Editors
Nelson Patterson has been elected to Pharma & Biopharma Outsourcing Association board.
BioPharm International: Jan 01, 2015
There are significant differences between small molecules and biologics fill/finish capacity.
BioPharm International: Dec 17, 2014
By BioPharm International Editors
New organization offers support to contract research organizations and contract manufacturing organizations in the New England area.
BioPharm International: Dec 01, 2014
Outsourcing is taking on a greater role in the biopharmaceutical manufacturing industry.
BioPharm International: Oct 31, 2014
European CDMOs want into the US market, but entry options are limited.
BioPharm International: Sep 30, 2014
The trend of exits from the CMO industry looks to be gaining momentum.